A study on clinico-immunologic response and virologic suppression rates of antiretroviral therapy in the treatment of naïve HIV-positive patients at a tertiary care hospital in Eastern India
Background: The tenofovir–lamivudine–efavirenz regimen was introduced in 2018, and there was a lack of data on the treatment trends in human immunodeficiency virus (HIV) patients in India. Therefore, we initiated this study. Objectives: Our objective was to evaluate the clinical and immunolog...
Saved in:
| Main Authors: | Madhuchhanda Mandal, Sabnam Parvin, Sonali Das |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
| Series: | MGM Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/mgmj/fulltext/2024/11030/a_study_on_clinico_immunologic_response_and.13.aspx |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
by: Zhenyan Wang, et al.
Published: (2024-11-01) -
Incidence of opportunistic infections and its predictors among HIV/AIDS patients on antiretroviral therapy in Gondar University Comprehensive and Specialized Hospital, Ethiopia
by: Mequanente Dagnaw, et al.
Published: (2023-12-01) -
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
by: Hernando Knobel, et al.
Published: (2023-12-01) -
Time to antiretroviral therapy initiation
in HIV-positive patients with opportunistic infections/AIDS-defining illness in Southern Thailand: a prospective cohort study
by: Chanadda Wuttikul, et al.
Published: (2024-04-01) -
The impact of adherence counseling incorporating a point of care urine tenofovir assay on virologic suppression among individuals failing tenofovir-lamivudine-dolutegravir: A pre-post intervention study
by: Leonard Bikinesi, et al.
Published: (2025-02-01)